Faeth Therapeutics, Inc. (FTH)

NASDAQ

$23.19

$-3.01

(-11.56%)

Pre-Market

Faeth Therapeutics, Inc. (FTH) Live Price Chart

Last updated: ⁦2026-10-13 08:19:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Faeth Therapeutics, Inc. (FTH) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $23.19, with a market capitalisation of $672.63M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $13.43 to $42.14. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$672.63M
Open	$26.00
Day's High	$42.14
Day's Low	$13.43
Previous Close	$26.03
Volume	291.85K
Average Volume	352.43K
P/E Ratio	--
52-Week High	$42.14
52-Week Low	$13.43
Dividend Yield	--
Earnings Date	--

Faeth Therapeutics, Inc. (FTH) Pre-Market Stock Price

Faeth Therapeutics, Inc. (FTH) is trading at $25.61 in pre-market trading as of 2026-10-12 23:59:00, down 1.61% ($0.42) from the previous close of $26.03

Pre-market trading shows how investors are pricing FTH before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Faeth Therapeutics, Inc. (FTH) 7-Day Stock Price Change

Over the past seven days, Faeth Therapeutics, Inc. (FTH) moved from $28.35 to $23.19, representing a decline of 18.19% ($5.16).

The stock traded between $23.00 and $29.64 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 295.12 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

FTH 52-Week Price Position

Position in Range: 34.0%

52W Low$13.43

52W High$42.14

FTH is currently trading at $23.19, placing it 34.0% of the way from its 52-week low of $13.43 to its 52-week high of $42.14. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Faeth Therapeutics, Inc. (FTH)?

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Faeth Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	29
Exchange	NASDAQ
Company Website	https://www.faeththerapeutics.com

How to Buy Faeth Therapeutics, Inc. (FTH) Stock on MEXC

Eligible investors can buy real shares of Faeth Therapeutics, Inc. (FTH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for FTH and Place Your Order

Open the RealStocks trading page and search for FTH. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Faeth Therapeutics, Inc. (FTH) stock price today?

Faeth Therapeutics, Inc. (FTH) is currently trading at $ 23.19, down 10.90% ($2.84) from the previous close of $ 26.03. Intraday prices update in real time during regular trading hours.

2.Is FTH stock going up or down today?

As of 2026-10-12 23:59:00, FTH is trading at $ 23.19, down 10.90% ($2.84) from its previous close of $ 26.03. The stock has traded between $ 13.43 and $ 42.14 during today’s regular session. Past price movements do not guarantee future results.

3.What is FTH pre-market price?

As of 2026-10-12 23:59:00, FTH is trading at $ 25.61 in pre-market trading, down 1.61% ($0.42) from the previous close of $ 26.03. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is FTH after-hours price?

As of 2026-10-12 23:59:00, FTH is trading at $ 23.08 in after-hours trading, down 11.33% ($2.95) from the regular-session close of $ 26.03. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is FTH stock trading now?

FTH trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does FTH sit relative to its 52-week high and low?

Over the past 52 weeks, FTH has traded between a low of $ 13.43 and a high of $ 42.14. At $ 23.19, the stock is positioned 34.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Faeth Therapeutics, Inc. in?

Faeth Therapeutics, Inc. (FTH) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Faeth Therapeutics, Inc.'s market capitalisation and where is it listed?

Faeth Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 672.63M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is FTH valued in terms of P/E ratio and EPS?

FTH trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -7.57. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Faeth Therapeutics, Inc. pay a dividend?

Faeth Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.